KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Other Accumulated Expenses (2018 - 2025)

Astrana Health (ASTH) has disclosed Other Accumulated Expenses for 10 consecutive years, with $335.7 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 1121.68% to $335.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $335.7 million through Dec 2025, up 1121.68% year-over-year, with the annual reading at $335.7 million for FY2025, 1121.68% up from the prior year.
  • Other Accumulated Expenses hit $335.7 million in Q4 2025 for Astrana Health, up from $334.0 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $335.7 million in Q4 2025 to a low of $27.5 million in Q4 2024.
  • Historically, Other Accumulated Expenses has averaged $118.5 million across 5 years, with a median of $96.6 million in 2022.
  • Biggest YoY gain for Other Accumulated Expenses was 1121.68% in 2025; the steepest drop was 83.3% in 2025.
  • Year by year, Other Accumulated Expenses stood at $55.8 million in 2021, then skyrocketed by 45.66% to $81.3 million in 2022, then skyrocketed by 31.26% to $106.7 million in 2023, then tumbled by 74.24% to $27.5 million in 2024, then skyrocketed by 1121.68% to $335.7 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for ASTH at $335.7 million in Q4 2025, $334.0 million in Q3 2025, and $29.8 million in Q2 2025.